Literature DB >> 8686303

Clinical uses for low-molecular-weight heparins.

G R Wise.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8686303      PMCID： PMC1303545     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  5 in total

Review 1.  Prevention of venous thromboembolism.

Authors:  G P Clagett; F A Anderson; J Heit; M N Levine; H B Wheeler
Journal:  Chest       Date:  1995-10       Impact factor: 9.410

2.  Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin.

Authors:  T E Warkentin; M N Levine; J Hirsh; P Horsewood; R S Roberts; M Gent; J G Kelton
Journal:  N Engl J Med       Date:  1995-05-18       Impact factor: 91.245

3.  Cost/benefit aspects on thromboprophylaxis.

Authors:  D Bergqvist; T Mätzsch
Journal:  Haemostasis       Date:  1993-03

4.  A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis.

Authors:  M Levine; M Gent; J Hirsh; J Leclerc; D Anderson; J Weitz; J Ginsberg; A G Turpie; C Demers; M Kovacs
Journal:  N Engl J Med       Date:  1996-03-14       Impact factor: 91.245

5.  Treatment of deep venous thrombosis with low-molecular-weight heparins. A meta-analysis.

Authors:  A W Lensing; M H Prins; B L Davidson; J Hirsh
Journal:  Arch Intern Med       Date:  1995-03-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.